202 related articles for article (PubMed ID: 33927627)
1. P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications.
Spinaci A; Buccioni M; Dal Ben D; Marucci G; Volpini R; Lambertucci C
Front Pharmacol; 2021; 12():653561. PubMed ID: 33927627
[No Abstract] [Full Text] [Related]
2. Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications.
Marucci G; Dal Ben D; Buccioni M; Martí Navia A; Spinaci A; Volpini R; Lambertucci C
Expert Opin Ther Pat; 2019 Dec; 29(12):943-963. PubMed ID: 31726893
[No Abstract] [Full Text] [Related]
3. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration.
Garceau D; Chauret N
Pulm Pharmacol Ther; 2019 Jun; 56():56-62. PubMed ID: 30902655
[TBL] [Abstract][Full Text] [Related]
4. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.
Jarvis MF; Burgard EC; McGaraughty S; Honore P; Lynch K; Brennan TJ; Subieta A; Van Biesen T; Cartmell J; Bianchi B; Niforatos W; Kage K; Yu H; Mikusa J; Wismer CT; Zhu CZ; Chu K; Lee CH; Stewart AO; Polakowski J; Cox BF; Kowaluk E; Williams M; Sullivan J; Faltynek C
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17179-84. PubMed ID: 12482951
[TBL] [Abstract][Full Text] [Related]
5. Variability in P2X receptor composition in human taste nerves: implications for treatment of chronic cough.
High B; Jetté ME; Li M; Ramakrishnan VR; Clary M; Prager J; Draf J; Hummel T; Finger TE
ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37057093
[TBL] [Abstract][Full Text] [Related]
6. Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2/3 receptors with in vivo efficacy in a pain model.
Ballini E; Virginio C; Medhurst SJ; Summerfield SG; Aldegheri L; Buson A; Carignani C; Chen YH; Giacometti A; Lago I; Powell AJ; Jarolimek W
Br J Pharmacol; 2011 Jul; 163(6):1315-25. PubMed ID: 21410458
[TBL] [Abstract][Full Text] [Related]
7. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
[TBL] [Abstract][Full Text] [Related]
9. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
[TBL] [Abstract][Full Text] [Related]
10. P2X2/3 and P2X3 receptors contribute to the metaboreceptor component of the exercise pressor reflex.
McCord JL; Tsuchimochi H; Kaufman MP
J Appl Physiol (1985); 2010 Nov; 109(5):1416-23. PubMed ID: 20798273
[TBL] [Abstract][Full Text] [Related]
11. P2X3 and P2X2/3 receptors activation induces articular hyperalgesia by an indirect sensitization of the primary afferent nociceptor in the rats' knee joint.
Teixeira JM; Parada CA; Tambeli CH
Eur J Pharmacol; 2020 Jul; 879():173054. PubMed ID: 32145326
[TBL] [Abstract][Full Text] [Related]
12. Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.
Richards D; Gever JR; Ford AP; Fountain SJ
Br J Pharmacol; 2019 Jul; 176(13):2279-2291. PubMed ID: 30927255
[TBL] [Abstract][Full Text] [Related]
13. 2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.
Neelands TR; Burgard EC; Uchic ME; McDonald HA; Niforatos W; Faltynek CR; Lynch KJ; Jarvis MF
Br J Pharmacol; 2003 Sep; 140(1):202-10. PubMed ID: 12967950
[TBL] [Abstract][Full Text] [Related]
14. Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats.
Kaan TK; Yip PK; Patel S; Davies M; Marchand F; Cockayne DA; Nunn PA; Dickenson AH; Ford AP; Zhong Y; Malcangio M; McMahon SB
Brain; 2010 Sep; 133(9):2549-64. PubMed ID: 20802203
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of P2X2 and P2X3 receptors in rats with hyperalgesia induced by heroin withdrawal.
Leng C; Chen L; Gong X; Ma B; Gan W; Si Y; Xiao H; Li C
Neuroreport; 2018 May; 29(8):678-684. PubMed ID: 29596152
[TBL] [Abstract][Full Text] [Related]
16. Calcium permeability and block at homomeric and heteromeric P2X2 and P2X3 receptors, and P2X receptors in rat nodose neurones.
Virginio C; North RA; Surprenant A
J Physiol; 1998 Jul; 510 ( Pt 1)(Pt 1):27-35. PubMed ID: 9625864
[TBL] [Abstract][Full Text] [Related]
17. P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE₂ or dopamine.
de Oliveira Fusaro MC; Pelegrini-da-Silva A; Araldi D; Parada CA; Tambeli CH
Eur J Pharmacol; 2010 Dec; 649(1-3):177-82. PubMed ID: 20868656
[TBL] [Abstract][Full Text] [Related]
18. DT-0111: a novel P2X3 receptor antagonist.
Pelleg A; Sirtori E; Rolland JF; Mahadevan A
Purinergic Signal; 2023 Sep; 19(3):467-479. PubMed ID: 36944825
[TBL] [Abstract][Full Text] [Related]
19. Potential applications of P2X3 receptor antagonists in the treatment of refractory cough.
Yi B; Wang S; Li W; Xu X; Yu L
Respir Med; 2023 Oct; 217():107336. PubMed ID: 37364722
[TBL] [Abstract][Full Text] [Related]
20. P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP.
Cockayne DA; Dunn PM; Zhong Y; Rong W; Hamilton SG; Knight GE; Ruan HZ; Ma B; Yip P; Nunn P; McMahon SB; Burnstock G; Ford AP
J Physiol; 2005 Sep; 567(Pt 2):621-39. PubMed ID: 15961431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
